tsn

Popularity of Obesity Drugs Are Creating a “Gray Market” in India

 163
7 comments
Writer at TrialSite News | Efficient
Jun. 21, 2024, 6:00 p.m.
Journalist Article

The popularity of diabetes drugs now being used for treatment of obesity has exploded worldwide. It is a cash cow for Big Pharma, and the success of the obesity drugs has altered the economy of a Nordic country as well as now starting to influence the food industry. According to The Wall Street Journal, 7% of the American population will be on weight loss drug and serious projections are that this metabolic space may well be worth north of $100 billion. With those kinds of numbers of course the investment sector monitors closely. How can they cash in on the economic prospects of the new wave of interest in the obesity market. But in a country where weight loss drugs are not as readily available a new “Gray Market” has emerged.

India

Quality journalism costs money to produce.

Free access provides up to 10 articles

Subscription options start at $5 per month 
which is less than a Starbucks coffee!

Peter Gabriel, MD
"Publishing on TrialSite helped me secure a $20m research grant for my work."
Jona Savinda
"TrialSiteNews is my daily read for what is happening in the industry."
Lucas Van Der Hoven
"Objective, unbiased reporting on the latest news in medical research. I trust TrialSiteNews to give it to me straight."
TrialSiteNews
159 W Broadway, Suite 200
Salt Lake City, UT 84101
© 2024 - Trial Site News